We have demonstrated a synergistic effect between KIFC1 silencing and cisplatin treatment, a therapy that induces centrosome amplification in cancer cells, on long-term clonal growth in culture and in vivo xenografts growth suggesting potential for combination approaches with a standard of care chemotherapy increasingly used in TNBC. This evidence concerns the gene KIFC1 and cancer.